For years, conventional wisdom held that skin improvements among patients on GLP-1 medications were a byproduct of weight loss, which reduces inflammation. But doctors are spotting a much more complex ...
French biopharma Sanofi has inked a partnership deal with Pangaea Data to use its AI platform that helps detect Alpha-1 Antitrypsin Deficiency (AATD), which will be distributed to select healthcare ...
Abstract: This paper proposes an automatic, image-based system to detect common skin diseases in dogs using deep learning and transfer learning techniques. To efficiently perform the classification of ...
More than 5 million cases of skin cancer are diagnosed annually in the United States, with melanoma cases sharply increasing over the past few decades. Early detection of melanoma is associated with a ...
When you start taking GLP-1s, you’re probably excited about the expected changes to your body. These medications were created to lower blood sugar for diabetes, but many are now popularly used for ...
Baseline biomarker analysis and clinical outcomes of the PD-1/TGFβR2 bispecific antibody INCA33890 in patients with non-MSI-H metastatic colorectal cancer (mCRC). This is an ASCO Meeting Abstract from ...
Coupling tumor genomics, whole transcriptome sequencing, and patient outcomes to define the tumor microenvironment in receptor tyrosine amplified gastrointestinal cancers: Analysis from 24,598 cases.
A tool for spotting pancreatic cancer in routine CT scans has had promising results, one example of how China is racing to apply A.I. to medicine’s tough problems. Self-service kiosks at the ...
Abstract: Detection of skin diseases is a very important branch of medical image analysis and, hence, early diagnosis is vital for the patient's recovery. This paper proposes an integrated multi-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results